Metabolic dysfunction–associated steatohepatitis (MASH) is a severe form of liver disease
that poses a global health threat because of its potential to progress to advanced fibrosis …

Non-alcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation,
and enlargement of the diameter of hepatocytes (ballooning hepatocytes), with or without …

Background The role of metabolic/inflammatory hormonal systems in metabolic dysfunction
associated steatotic liver disease (MASLD) remains to be fully elucidated. Purpose To report …

Insulin like growth factor-1 (IGF-1) plays important roles in metabolic functions, especially in
adulthood. Additionally, obese subjects are reportedly predisposed to having low absolute …

Background and aim Overweight and obesity are associated with the development of
several health complications, such as diabetes, cancer, and cardiovascular disease. Chia …

Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease
(NAFLD), characterized with hepatocellular steatosis, ballooning, lobular inflammation …

Adiponectin, as an indispensable regulator of the immune system, is the most abundant
adipokine and is mainly produced by white adipose tissue. Adiponectin mediates the …

Background Adiposity and non-alcoholic fatty liver disease (NAFLD) are common
characteristics of metabolic syndrome (MS). Understanding the underlying pathogenesis is …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
throughout the world. Hepatocellular carcinoma (HCC) and liver cirrhosis can result from …

Background. Nonalcoholic fatty liver disease (NAFLD) is a prevalent form of liver damage,
affecting~ 25% of the global population. NAFLD comprises a spectrum of liver pathologies …